The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 07, 2020

Filed:

Nov. 29, 2012
Applicant:

St Pharm Co., Ltd., Siheung-si, KR;

Inventors:

Young Ro Byun, Seoul, KR;

Al-Hilal Taslim Ahmed, Seoul, KR;

Ok Cheol Jeon, Seoul, KR;

Hyun Tae Moon, Seoul, KR;

Kyungjin Kim, Siheung-si, KR;

Jisuk Yun, Siheung-si, KR;

Assignee:

ST PHARM CO., LTD., Siheung-Si, Gyeonggi-do, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/727 (2006.01); C07K 14/62 (2006.01); C07K 14/605 (2006.01); A61K 9/00 (2006.01); A61K 49/04 (2006.01); B82Y 5/00 (2011.01); A61K 47/54 (2017.01); A61K 38/16 (2006.01); A61K 38/26 (2006.01);
U.S. Cl.
CPC ...
A61K 31/727 (2013.01); A61K 9/0053 (2013.01); A61K 38/16 (2013.01); A61K 38/26 (2013.01); A61K 47/542 (2017.08); A61K 47/554 (2017.08); A61K 49/0423 (2013.01); B82Y 5/00 (2013.01); C07K 14/605 (2013.01); C07K 14/62 (2013.01);
Abstract

The present invention relates to a method for preparing an end site-specific macromolecule-bile acid oligomer conjugate, comprising conjugating a bile acid oligomer which is prepared by oligomerization of two or more bile acid monomers to the terminal site of a macromolecule; a method for body absorption of an end site-specific macromolecule-bile acid oligomer conjugate, comprising administering the macromolecule-bile acid oligomer conjugate prepared by the above method to a subject orally; an end site-specific macromolecule-bile acid oligomer conjugate wherein the bile acid oligomer is conjugated to the terminal site of macromolecule; a composition comprising the conjugate; an oral formulation for macromolecule comprising the conjugate, a solubilizer, an excipient, a disintegrant, a binder, and a lubricant; a pharmaceutical composition comprising a heparin-bile acid oligomer conjugate wherein the bile acid oligomer is conjugated to the terminal site of heparin; and a method for treating thrombosis using said composition.


Find Patent Forward Citations

Loading…